Status:
RECRUITING
The Effects of Time Points to Cease Parenteral Nutrition and IGF-1 on Very Low Birth Weight Infants
Lead Sponsor:
Peking University
Conditions:
Growth Retardation
Eligibility:
All Genders
Brief Summary
This study aims to estimate short-term and long-term effects of time points to cease parenteral nutrition on very preterm infants, such as growth; to estimate the role of insulin-like growth factor 1 ...
Detailed Description
At present, it is unclear when to cease parenteral nutrition, the effects of cessation times on preterm infants' growth, and whether insulin-like growth factor 1 (IGF-1) has a mediation effect in the ...
Eligibility Criteria
Inclusion
- Infants with a birth weight less than 1500 grams
- Infants admitted within 72 hours after birth
- Infants born from July 1, 2023, to June 30, 2024
- Written informed consent from parents or guardians
Exclusion
- Infants with congenital abnormality
- Infants surviving \<7 days after birth
Key Trial Info
Start Date :
July 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
416 Patients enrolled
Trial Details
Trial ID
NCT06071403
Start Date
July 1 2023
End Date
September 30 2026
Last Update
October 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wei Guo
Xingtai, Hebei, China